Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2026
Translating Innovation Into Practice: Dissemination of Immune Checkpoint Inhibitors and Their Toxicity Management Across the GlobeMehak Trikha, Susan Dent, Kaysia Ludford, et al.
South Asian Journal of Cancer|December 31, 2025
Practice Patterns and Incidence of F ebrile Neutr o penia in Patients R eceiving T riplet Drug Chemotherapeutic Regimens in G U T Cancers: Do We Need to Add WBC Growth Factors? (ForGeT GCSF Study)Kapu Venkatesh, Anant Ramaswamy, Noorzia Sultana, et al.
Ecancermedicalscience|October 18, 2024
The use of immune checkpoint inhibitors in advanced gastric/gastroesophageal adenocarcinomas - real-world evidence and the use of alternative dosingAditya Dhanawat, Mehak Trikha, Manan Vora, et al.
The Indian Journal of Medical Research|April 11, 2023
Modified FOLFIRINOX compared to Gemcitabine & nab-Paclitaxel in advanced pancreatic ductal adenocarcinoma - results of a match-pair analysisAnant Ramaswamy, Darshit Shah, Prabhat Bhargava, et al.
Ecancermedicalscience|June 10, 2025
Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in IndiaMehak Trikha, Vanita Noronha, Minit Shah, et al.
South Asian Journal of Cancer|December 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from IndiaAjaykumar Singh, Vanita Noronha, Vijay Patil, et al.
JCO Global Oncology|August 19, 2024
Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD-High Study)Mehak Trikha, Laboni Sarkar, Aditya Dhanawat, et al.
Ecancermedicalscience|July 3, 2025
Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in IndiaSushmita Rath, Mehak Trikha, Laboni Sarkar, et al.
South Asian Journal of Cancer|December 31, 2025
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, IndiaAtul Tiwari, Ajay Kumar Singh, Vanita Noronha, et al.
JCO Global Oncology|December 5, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From IndiaVamshi Krishna Muddu, Anjali Shah, Anupa John, et al.
Pageof 2